Ubs Group Ag Seer, Inc. Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Seer, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 54,168 shares of SEER stock, worth $91,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,168

Previous 47,016 15.21%

Holding current value

$91,002

Previous $91,000 12.09%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.54 - $2.09 $11,014 - $14,947	7,152 Added 15.21%	54,168 $102,000
Q4 2023 Feb 09, 2024	BUY	$1.47 - $2.22 $16,502 - $24,921	11,226 Added 31.37%	47,016 $91,000
Q3 2023 Nov 09, 2023	SELL	$2.18 - $5.52 $32,388 - $82,010	-14,857 Reduced 29.33%	35,790 $79,000
Q2 2023 Aug 11, 2023	BUY	$3.16 - $4.96 $92,417 - $145,060	29,246 Added 136.66%	50,647 $216,000
Q1 2023 May 12, 2023	SELL	$3.6 - $5.88 $22,172 - $36,214	-6,159 Reduced 22.35%	21,401 $82,000

Q4 2022 Feb 08, 2023	BUY	$5.03 - $8.58 $106,490 - $181,647	21,171 Added 331.37%	27,560 $159,000
Q3 2022 Nov 10, 2022	BUY	$7.7 - $13.31 $36,474 - $63,049	4,737 Added 286.74%	6,389 $49,000
Q2 2022 Aug 10, 2022	SELL	$6.72 - $16.07 $26,241 - $62,753	-3,905 Reduced 70.27%	1,652 $15,000
Q1 2022 May 16, 2022	SELL	$11.88 - $23.4 $188,238 - $370,773	-15,845 Reduced 74.04%	5,557 $85,000
Q4 2021 Feb 14, 2022	SELL	$21.08 - $38.51 $433,742 - $792,381	-20,576 Reduced 49.02%	21,402 $489,000
Q3 2021 Nov 15, 2021	BUY	$27.67 - $45.04 $1.15 Million - $1.88 Million	41,661 Added 13142.27%	41,978 $1.45 Million
Q2 2021 Aug 13, 2021	SELL	$28.75 - $56.92 $36,742 - $72,743	-1,278 Reduced 80.13%	317 $11,000
Q1 2021 May 12, 2021	BUY	$38.67 - $84.06 $61,678 - $134,075	1,595 New	1,595 $80,000

Others Institutions Holding SEER

# of Institutions

Shares Held

42.9M

Call Options Held

200

Put Options Held

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $98.4M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account